@article{a635df3054a745d2b626de424d0a62b3,
title = "Reply to: “COVID-19, syphilis, and biologic therapies for psoriasis and psoriatic arthritis: A word of caution”",
author = "Mark Lebwohl and Ryan Rivera-Oyola and Murrell, {Dedee F.}",
note = "Funding Information: Conflicts of interest: Dr Lebwohl is an employee of Mount Sinai, receives research funds from AbbVie, Amgen, Eli Lilly, Janssen Research & Development, LLC, Novartis, Ortho Dermatologics, and UCB, Inc, and has been the principal investigator for numerous clinical trials but has no personal financial gain. Dr Murrell is an employee of St George Hospital, has been an investigator/advisor for Novartis, Sun Pharma, Janssen and AbbVie, and is also the director of a clinical trial center for dermatologic diseases. Ryan Rivera-Oyola has no relevant conflicts of interest. Funding sources: None.",
year = "2020",
month = jun,
doi = "10.1016/j.jaad.2020.03.103",
language = "English",
volume = "82",
pages = "e215",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Elsevier Inc.",
number = "6",
}